跳到正文
原文
NEJM· @NEJM · X·· 17 天前AI 评分18
AI 导读

一篇新综述中的图2展示了美国已获批、对特定革兰阴性耐药感染具有活性的静脉β-内酰胺类药物。阅读完整综述了解更多:https://nej.md/4yIbmfe

正文

Figure 2 from a new review shows approved intravenous β-lactam agents available in the United States with activity against selected gram-negative antimicrobial-resistant infections. Read the full review to learn more: https://nej.md/4yIbmfe

来源:NEJM · x.com